Screening for PCa could be possible within five years, says a leading UK expertÂ (Dec ’21). See more here
We publish several newsletters throughout the year. These provide the latest news and information about the Prospect group and PCa in general.Â The Summer ’23 newsletter is downloadable via this link (click link or right click and save as…). This issue of the newsletter has news about our summer meetings, the botanic garden tour and the docks walk. There is also an article on psychological approaches in recovery. David Casley, Prospect Publicity 07860 369064;Â EmailÂ email@example.com
The Oxford-Astra Zeneca Covid vaccine technology has been used to design a jab that could treat cancer (Sept ’21). Sky News
Advanced PCa patients can take enzalutamide or abiraterone at home instead of going into hospital for chemotherapy, NHS England says. It will relieve pressure on the NHS. The drugs are smarter, kinder treatments and could extend the lives of many more men, itâ€™s said (May â€™20). More here. And a new treatment is being tested that could extend the lives of men with advanced prostate cancer, by killing cancer in the prostate despite the disease having spread. The nationwide Atlanta trial, at Imperial College London, was recruiting 918 newly-diagnosed men. More here
Scientists have created a â€śTrojan horseâ€ť that sneaks nanoparticles into cancer cells and causes them to self-destruct. The research is still in its early days, but the new method has already proved to be effective at killing cancer cells in a petri dish and reducing tumour growth in mice. See more
A Bristol man is the first NHS patient to have a device implanted which can reduce the side effects of radiotherapy by 70% (see more here). And a trial to spare the nerves around the prostate during surgery is being held at Southmead Hospital. If successful, it will reduce the risk of erectile disfunction and will be available throughout England.
Hundreds of UK men are trying out a non-invasive MRI scan for PCa to see if it should eventually be offered routinely on the NHS. The scan takes images to check for any abnormal growths. It will take a few years to know if MRI will be better than PSA tests and biopsies at spotting cancers (Jun ’19). In this article, a professor explains why finding a suitable screening method is vital but has proved difficult. And Prostate Cancer UK said the news made headlines but journalists “can be overly enthusiastic about new research” and put the record straight here. And an academic article on this is to be found here
AN NHS tool is now available – intended for men with non-metastatic PCa who are deciding between conservative and radical management regimes. It is intended only for men with non-metastatic prostate cancer who are deciding between these regimes. Itâ€™s recommend that patients use this tool in consultation with their doctor (Apr â€™19). See here. And four new technologies that will tame the immune system are getting us closer to a future where cancer becomes curable. See more here
Untire has become the first Cancer-Related Fatigue (CRF) app to be approved by the NHS, and is now available to download for free via the NHS apps library. It aims to tackle CRF, one of the most common side effects of cancer and its treatment (Aug â€™19). See more at
A new US study sheds light on a signalling circuit in cells that drives therapy resistance in PCa. Targeting the components of this circuit suppresses advanced cancer development. See here.
A radioactive drug, which behaves like the substance used to kill Russian ex-spy Alexander Litvinenko, could be used to treat PCa patients. It targets tumours that have spread to the bones and has been approved by NICE. See here